Medications

New drug candidate slows the progression of adrenoleukodystrophy

The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective ...

Neuroscience

Fresh insights into inflammation, aging brains

Results from a new study by Harvard researchers just published in Cell offer insights into the relationship between inflammation and the cognitive impairment we experience as we age, and suggest the possibility that it may ...

Medical research

Multiple sclerosis drug works in a surprising way

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce ...

page 1 from 14